Institutional members access full text with Ovid®

Share this article on:

Use of Conventional Fractionation With Cyberknife in Children: A Report of 5 Cases

Peugniez, Charlotte MD*; Dewas, Sylvain MD*; Coche-Dequéant, Bernard MD*; Leblond, Pierre MD; Defachelles, Anne-Sophie MD; Thebaud, Estelle MD; Lacornerie, Thomas PhD*; Lartigau, Eric MD, PhD*

Journal of Pediatric Hematology/Oncology: August 2010 - Volume 32 - Issue 6 - pp 472-475
doi: 10.1097/MPH.0b013e3181e79332
Clinical and Laboratory Observations

The use of stereotactic radiotherapy with CyberKnife (Accuray Incorporated, Sunnyvale, CA) in adults is becoming more and more established. For children, there is no such consensus and the appropriate approach to this type of treatment is still debated. In the meantime, there seems to be a number of certain pediatric cases in which the use of CyberKnife within very strict limits is potentially justified. Here, we report the feasibility of and acute tolerance to radiotherapy with CyberKnife using conventional fractionation in 5 children.

*Département Universitaire de Radiothérapie, CyberKnife Nord-Ouest, Centre Oscar Lambret, CLCC, Université Lille II

Unité d'Oncologie Pédiatrique, Centre Oscar Lambret, CLCC, Lille

Researchers do not have any actual or potential conflicts of interest to declare

Reprints: Charlotte Peugniez, MD, Centre Oscar Lambret, 3 rue Frédéric Combemale 59000 Lille (e-mail: c.peugniez@orange.fr).

Received for publication February 5, 2010; accepted March 28, 2010

© 2010 Lippincott Williams & Wilkins, Inc.